---
title: "Pfizer and Moderna Hike the Price of COVID Vaccines"
description: "Both Moderna and Pfizer raised the price per dose of their COVID-19 vaccines in newly-negotiated contracts with the European Union."
date: "2021-08-02"
modified: "2021-08-02"
authors:
  - name: "Dan Robitzski"
    link: "https://futurism.com/authors/danrobitzski"
url: "https://futurism.com/neoscope/pfizer-moderna-hike-price-covid-vaccines"
categories:
  - "Health & Medicine"
  - "Medical"
  - "Pathogens"
  - "Viruses"
tags:
  - "coronavirus"
  - "covid19"
  - "health"
  - "moderna"
  - "pfizer"
  - "vaccine"
---

# Pfizer and Moderna Hike the Price of COVID Vaccines

![Both Moderna and Pfizer raised the price per dose of their COVID-19 vaccines in newly-negotiated contracts with the European Union.](<https://futurism.com/wp-content/uploads/2021/08/pfizer-moderna-hike-price-covid-vaccines.jpg>)
*\<em\>Image: Pxfuel/Victor Tangermann\</em\>*

Thanks to newly renegotiated contracts between the European Union and pharmaceutical giants Pfizer and Moderna, vaccines are about to become a lot more expensive for some countries.

European nations will now pay 25 percent more for Pfizer's COVID-19 vaccines and 10 percent more for Moderna's, [the *Financial Times* reports](<https://www.ft.com/content/d415a01e-d065-44a9-bad4-f9235aa04c1a>), bringing a Pfizer dose from $18.40 to $23.15 and a Moderna dose $22.60 to $25.50. As [*Gizmodo* notes](<https://gizmodo.com/pfizer-raises-price-of-covid-19-vaccine-by-25-in-europ-1847383399>), European governments will still distribute the shots to citizens for free, but the new price hikes illustrate [just how lucrative](<https://futurism.com/neoscope/pharma-execs-scheming-money-covid-vaccine>) the pandemic is becoming for the two pharma companies.

It shouldn't necessarily come as a shock that the companies are seeking a higher profit from the vaccine. Even though [Moderna took $483 million](<https://futurism.com/neoscope/pharma-execs-plan-profit-covid19-vaccine>) in grant funding from the US government and Pfizer's partner firm [BioNTech collected $445 million](<https://www.bloomberg.com/news/articles/2020-11-09/pfizer-vaccine-s-funding-came-from-berlin-not-washington>) from Germany, both companies were upfront about their plan to make money off the vaccine rather than selling it at cost like AstraZeneca.

Though Pfizer CEO Albert Bourla didn't *directly* connect the higher costs in Europe to lower costs elsewhere in his [second-quarter earnings call statement](<https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Conference-Call-Prepared-Remarks-FINAL.pdf>) last week, he did point out that the company will sell discounted vaccines to poorer nations around the world.

"We anticipate that a significant amount of our remaining 2021 vaccine manufacturing capacity will be delivered to middle- and low-income countries where we price in line with income levels or at a not-for-profit price," Bourla said. "In fact, we are on track to deliver on our commitment to provide this year more than 1 billion doses, or approximately 40 percent of our total production, to middle- and low-income countries, and another 1 billion in 2022."

## Author
Dan Robitzki is a senior reporter for Futurism, where he likes to cover AI, tech ethics, and medicine. He spends his extra time fencing and streaming games from Los Angeles, California.

### Author social links  
[Twitter](<https://x.com/danrobitzski>)